Highly efficient cellular expression of circular mRNA enables prolonged protein expression

Mildred J Unti1, Samie R Jaffrey1

  • 1Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.

Cell Chemical Biology
|October 26, 2023
PubMed

Insights

Researchers developed a new method for creating circular messenger RNA (mRNA) inside cells, leading to longer protein production and improved therapeutic potential for mRNA vaccines and treatments.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • RNA Therapeutics

Background:

  • Messenger RNA (mRNA) therapeutics face rapid degradation in cells, limiting their effectiveness.
  • Circular mRNA offers a longer half-life, enhancing protein synthesis duration.
  • Current methods for producing circular mRNA are primarily in vitro, posing challenges for in-cell applications.

Purpose of the Study:

  • To adapt the Tornado system for efficient in-cell synthesis of circular mRNA.
  • To identify optimal promoter and internal ribosomal entry site (IRES) combinations for high circular mRNA and protein expression.
  • To demonstrate the utility of in-cell synthesized circular mRNA in virus-like particle (VLP) therapeutics.

Main Methods:

  • Adaptation of the Tornado (Twister-optimized RNA for durable overexpression) system for intracellular circular mRNA production.
  • Screening of various promoters and IRES elements to optimize circular mRNA synthesis.
  • Packaging of synthesized circular mRNA into virus-like particles (VLPs).

Main Results:

  • Successful adaptation of the Tornado system for in-cell circular mRNA synthesis.
  • Identification of specific promoter-IRES combinations yielding high levels of circular mRNA and subsequent protein expression.
  • Demonstration that circular mRNA can be effectively packaged into VLPs for sustained protein expression.

Conclusions:

  • The developed platform enables efficient in-cell synthesis of circular mRNA.
  • This approach significantly enhances protein expression duration compared to linear mRNA.
  • In-cell synthesized circular mRNA holds promise for improving VLP-based therapeutics.